{"id":"CHEMBL104264","canonicalSmiles":"O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12","inchiKey":"ZKZXNDJNWUTGDK-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"H-89","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["H-89"],"crossReferences":{"PubChem":["26755654","26755655","50110953"],"drugbank":["DB07995"]},"childChemblIds":["CHEMBL1315166"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1060","canonicalSmiles":"O=P([O-])([O-])O.[Na+].[Na+]","inchiKey":"BNIILDVGGAEEIG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHOSPHATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neutral sod phos"],"synonyms":["E-339(II)","FEMA NO. 2398","INS NO.339(II)","INS-339(II)","Sodium phosphate","Sodium phosphate dibasic","Sodium phosphate, dibasic anhydrous","Sodium phosphate, dibasic, anhydrous"],"crossReferences":{"DailyMed":["sodium%20phosphate","sodium%20phosphate,%20dibasic,%20anhydrous"],"DrugCentral":["4219"],"Wikipedia":["Disodium_phosphate"],"drugbank":["DB14502"],"chEBI":["34683"]},"childChemblIds":["CHEMBL2107560","CHEMBL2107525"],"count":1,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for constipation."}
{"id":"CHEMBL1078549","canonicalSmiles":"C[C@@]12C[C@@]3(O)O[C@@H](O1)[C@]1(COC(=O)c4ccccc4)[C@@H]3C[C@@]21O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"YKRGDOXKVOZESV-QYDSDWLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAEONIFLORIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-178886","Paeoniflorin","Peoniflorin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1080759","canonicalSmiles":"COc1cc2c(cc1C(N)=O)CC[C@@H]1[C@@H]2CC[C@]2(C)C=CC[C@@H]12","inchiKey":"YQJWOUQGXATDAE-ACNBBOPNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1080759","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05959"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1094966","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)n1","inchiKey":"VQDBNKDJNJQRDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRBUTEROL","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pirbuterol"],"crossReferences":{"Wikipedia":["Pirbuterol"],"drugbank":["DB01291"],"chEBI":["8245"]},"childChemblIds":["CHEMBL1997417","CHEMBL3989646","CHEMBL1200444"],"count":1,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000270"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for airway obstruction."}
{"id":"CHEMBL1096885","canonicalSmiles":"CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O","inchiKey":"ZOCKGBMQLCSHFP-KQRAQHLDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALRUBICIN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Valstar","Valstar preservative free"],"synonyms":["AD 32","AD-32","NSC-246131","Valrubicin"],"crossReferences":{"PubChem":["144205810"],"Wikipedia":["Valrubicin"],"drugbank":["DB00385"]},"count":4,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0008528","EFO_0006544","MONDO_0004647","MONDO_0001187"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for neoplasm and has 3 investigational indications."}
{"id":"CHEMBL1159717","canonicalSmiles":"CC(C)(C)NCC(O)c1ccccc1Cl","inchiKey":"YREYLAVBNPACJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TULOBUTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brelomax","Respacal"],"synonyms":["Tulobuterol","Tulobuterol hydrochloride"],"crossReferences":{"PubChem":["90340621"],"Wikipedia":["Tulobuterol"],"drugbank":["DB12248"]},"childChemblIds":["CHEMBL1256478"],"count":1,"approvedIndications":["HP_0006536"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL1159973","canonicalSmiles":"CCCCCCCCOC[C@H](COP(=O)(O)OCCN)OP(=O)(O)CCCCCCC","inchiKey":"RCCNUBYROFOKAU-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1159973","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03565"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1171433","canonicalSmiles":"O=S(=O)(O)Cc1ccccc1","inchiKey":"NIXKBAZVOQAHGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLMETHANESULFONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenylmethanesulfonic Acid"],"crossReferences":{"drugbank":["DB03297"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL118722","canonicalSmiles":"CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC","inchiKey":"UYXTWWCETRIEDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBUTYRIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 2223","NSC-661583","Tributyrin"],"crossReferences":{"PubChem":["509766"],"drugbank":["DB12709"],"chEBI":["35020"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1187694","canonicalSmiles":"OC(c1ccccc1)(c1ccccc1)C1CN2CCC1CC2","inchiKey":"PZMAHNDJABQWGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUIFENADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quifenadine"],"crossReferences":{"PubChem":["144205405","29216174"],"drugbank":["DB13713"]},"childChemblIds":["CHEMBL1510616","CHEMBL515462"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1196","canonicalSmiles":"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N","inchiKey":"KCLANYCVBBTKTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPARACAINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alcaine","Kainair","Ophthaine","Ophthetic","Paracaine","Proparacaine","Proxymetacaine"],"crossReferences":{"DailyMed":["proparacaine%20hydrochloride"],"PubChem":["11112907","124882712","174006303"],"Wikipedia":["Proxymetacaine"],"drugbank":["DB00807"],"chEBI":["8485"]},"childChemblIds":["CHEMBL1200464"],"count":1,"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["HP_0009926","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and has 1 investigational indication."}
{"id":"CHEMBL1200363","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.O=S(=O)(O)O","inchiKey":"KTXVDQNRHZQBOR-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENBUTOLOL SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1290","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Levatol"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200395","canonicalSmiles":"Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"MMMNTDFSPSQXJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORPHENADRINE CITRATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL900","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Norflex","Orphenadrine citrate"],"synonyms":["Orphenadine citrate","Orphenadrine (citrate)","Orphenadrine Citrate","Orphenadrine citrate"],"crossReferences":{"DailyMed":["orphenadrine%20citrate"],"PubChem":["11532864","144204876","144207092","144211396","170464910","26748176"],"chEBI":["7790"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000103546","ENSG00000116032","ENSG00000136546","ENSG00000198785","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000161509","ENSG00000185313","ENSG00000183873","ENSG00000144285","ENSG00000105464","ENSG00000169432","ENSG00000176884","ENSG00000196639","ENSG00000136531","ENSG00000153253"],"count":19},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for pain."}
{"id":"CHEMBL1200688","canonicalSmiles":"CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C","inchiKey":"NSYZCCDSJNWWJL-YXOIYICCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN ETHYLSUCCINATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arpimycin","E-mycin","E-mycin e","E.e.s.","E.e.s. 200","E.e.s. 400","Erymin","Eryped","Erythroden","Erythromycin ethylsuccinate","Erythroped","Erythroped a","Erythroped fte","Erythroped fte sf","Erythroped pi","Erythroped pi sf","Erythroped sf","Pediamycin","Pediamycin 400","Primacine","Rommix 125","Wyamycin","Wyamycin e"],"synonyms":["Erythromycin ethyl succinate","Erythromycin ethylsuccinate"],"crossReferences":{"DailyMed":["erythromycin%20ethylsuccinate"],"PubChem":["144207046","46500619","49648467","855551"],"TG-GATEs":["82"],"chEBI":["31555"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 2 investigational indications."}
{"id":"CHEMBL1200770","canonicalSmiles":"CC(=O)N(CC(C)C(=O)O)c1c(I)cc(I)c(N)c1I","inchiKey":"GSVQIUGOUKJHRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOCETAMIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cholebrine"],"synonyms":["Iocetamic acid","MP-620"],"crossReferences":{"PubChem":["144204131","56463701"],"Wikipedia":["Iocetamic_acid"],"drugbank":["DB09403"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200814","canonicalSmiles":"CC(=O)Nc1nnc(S([NH-])(=O)=O)s1.[Na+]","inchiKey":"MRSXAJAOWWFZJJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETAZOLAMIDE SODIUM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL20","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetazolamide sodium","Diamox"],"synonyms":["Acetazolamide Sodium","Acetazolamide sodium"],"crossReferences":{"chEBI":["31163"]},"count":3,"approvedIndications":["MONDO_0001744","HP_0001250","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000167434","ENSG00000133742","ENSG00000104267","ENSG00000074410"],"count":4},"linkedDiseases":{"rows":["MONDO_0001744","HP_0001250","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 approved indications."}
{"id":"CHEMBL1200927","canonicalSmiles":"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"DBAKFASWICGISY-DASCVMRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXCHLORPHENIRAMINE MALEATE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201353","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexchlorpheniramine maleate","Mylaramine","Polaramine"],"synonyms":["Chlorpheniramine d-form maleate","D-chlorpheniramine maleate","Dexchlorpheniramine maleate"],"crossReferences":{"DailyMed":["dexchlorpheniramine%20maleate"],"PubChem":["26747471","26747472","49681543","50106017"],"drugbank":["DB09555"],"chEBI":["4465"]},"count":9,"approvedIndications":["EFO_0005854","EFO_0005531","EFO_0007533","EFO_0007141","EFO_0005532","EFO_1001417","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003885","EFO_0005531","EFO_0007533","MONDO_0024352","EFO_0007141","EFO_0005532","EFO_1001417","EFO_0003785","EFO_0003956"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 7 approved and 2 investigational indications."}
{"id":"CHEMBL1201056","canonicalSmiles":"CCn1ccc(NS(=O)(=O)c2ccc(N)cc2)nc1=O","inchiKey":"SIBQAECNSSQUOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACYTINE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Renoquid"],"synonyms":["CI-636","Sulfacitine","Sulfacytine"],"crossReferences":{"PubChem":["170465286"],"Wikipedia":["Sulfacytine"],"drugbank":["DB01298"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975."}
{"id":"CHEMBL1201067","canonicalSmiles":"CC(O)C(=O)O.OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2","inchiKey":"GLPUBCPQWZZFNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIPERIDEN LACTATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1101","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akineton"],"synonyms":["Biperiden lactate"],"count":1,"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["MONDO_0043510"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and has 1 investigational indication."}
{"id":"CHEMBL1201222","canonicalSmiles":"C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN","inchiKey":"VOBHXZCDAVEXEY-JSGCOSHPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LISDEXAMFETAMINE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lisdexamfetamine"],"crossReferences":{"DailyMed":["lisdexamfetamine%20dimesylate"],"Wikipedia":["Lisdexamfetamine"],"drugbank":["DB01255"]},"childChemblIds":["CHEMBL1201178"],"count":7,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319","ENSG00000165646"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","EFO_0005204","EFO_0002610","MONDO_0002009","EFO_0001073","EFO_0004698","EFO_0003885","HP_0100543","EFO_0000289","MONDO_0002050","EFO_0004701","EFO_0000692","EFO_0003922"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for attention deficit hyperactivity disorder and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201269","canonicalSmiles":"CC(C)(N)Cc1ccc(Cl)cc1","inchiKey":"ZCKAMNXUHHNZLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENTERMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Cardiotoxicity"],"year":1969},"tradeNames":[],"synonyms":["Chlorphentermine"],"crossReferences":{"PubChem":["29216103"],"Wikipedia":["Chlorphentermine"],"drugbank":["DB01556"],"chEBI":["3646"]},"childChemblIds":["CHEMBL1200595"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982. It was withdrawn in Germany  in 1969 due to Cardiotoxicity."}
{"id":"CHEMBL1201361","canonicalSmiles":"C[C@@H]1C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl","inchiKey":"FJXOGVLKCZQRDN-PHCHRAKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCLOMETASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Alclometasone"],"drugbank":["DB00240"],"chEBI":["53776"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201379","canonicalSmiles":"O=C(O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1","inchiKey":"WWSWYXNVCBLWNZ-QIZQQNKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPROSTENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluprostenol"],"crossReferences":{"PubChem":["144205331","26754611","29216067"],"drugbank":["DB11519"],"chEBI":["60782"]},"childChemblIds":["CHEMBL2107435"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201589","drugType":"Antibody","blackBoxWarning":true,"name":"OMALIZUMAB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xolair"],"synonyms":["Hs632","IGE25","OLIZUMAB","Omalizumab","RG-3648","RHUMAB-E25"],"crossReferences":{"DailyMed":["omalizumab"],"DrugCentral":["4972"],"Wikipedia":["Omalizumab"]},"count":23,"approvedIndications":["HP_0006536","EFO_0005531","EFO_0000270"],"linkedTargets":{"rows":["ENSG00000211891"],"count":1},"linkedDiseases":{"rows":["Orphanet_2314","EFO_0007486","EFO_0007425","EFO_0008507","EFO_0000274","MONDO_0021063","EFO_0000540","EFO_0005531","EFO_0002690","EFO_1001881","EFO_0005854","EFO_0009661","EFO_0005532","EFO_0003818","MONDO_0004784","EFO_0009482","MONDO_0001085","EFO_0007187","EFO_0004232","HP_0006536","EFO_1000685","EFO_1001463","EFO_0000270","EFO_1001890","EFO_0000341","EFO_0003785","EFO_0007369","EFO_0003956"],"count":28},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1204059","canonicalSmiles":"C[C@H]1CN(C(=O)[C@@H]2CN(C(C)(C)C)C[C@H]2c2ccc(F)cc2F)C[C@@H](C)[C@]1(O)c1ccccc1.Cl","inchiKey":"WWCBDWDDPAPGHX-UZEFPFOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1204059","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1090488","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1204644","canonicalSmiles":"CN(CC(=O)O)C(=N)NP(=O)(O)O","inchiKey":"DRBBFCLWYRJSJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFOCREATINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Creatine phosphate","Fosfocreatine","Phosphocreatine"],"crossReferences":{"drugbank":["DB13191"],"chEBI":["17287"]},"childChemblIds":["CHEMBL7649"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1208302","canonicalSmiles":"CCCCCCCCCCS(=O)(=O)O","inchiKey":"KVGOXGQSTGQXDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1208302","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06893"]},"childChemblIds":["CHEMBL538615"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL121","canonicalSmiles":"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1","inchiKey":"YASAKCUCGLMORW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ROSIGLITAZONE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Cardiotoxicity"],"year":2010},"tradeNames":["Avandia"],"synonyms":["Avandamet","Avandaryl","Avandia","BRL-49653","Rosiglitazone","TDZ-01"],"crossReferences":{"DailyMed":["rosiglitazone%20maleate"],"PubChem":["144204987","170465417","174007204","26748954"],"Wikipedia":["Rosiglitazone"],"drugbank":["DB00412"],"chEBI":["50122"]},"childChemblIds":["CHEMBL843","CHEMBL1704605"],"count":34,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","HP_0002745","EFO_0007444","EFO_0003095","EFO_0001065","EFO_0000249","EFO_0004234","EFO_1001249","MONDO_0007254","EFO_0000373","EFO_1001110","EFO_0003914","EFO_1000783","HP_0100543","EFO_0000673","EFO_0004272","EFO_0003047","EFO_1000785","EFO_0000400","EFO_0002546","EFO_0000692","EFO_1000158","EFO_0000616","EFO_0000685","EFO_0006859","HP_0001952","HP_0003124","EFO_0006911","EFO_0001645","EFO_0004236","EFO_0000660","Orphanet_309005","EFO_0000537","EFO_0000311","EFO_0000195","EFO_0000589","EFO_0001068","EFO_0002614","EFO_0000270","EFO_0001359","EFO_1001121","EFO_0000764","EFO_1001373","EFO_1001051","EFO_0001360","EFO_0000691","EFO_0003767"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for diabetes mellitus and has 33 investigational indications. It was withdrawn in European Union  in 2010 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1221657","canonicalSmiles":"NCc1ccc(C(=O)N2CCC3(CC2)N=C(N)c2c(F)cccc2N3)cc1","inchiKey":"SFPCNWQWKOUNRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08750"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229585","canonicalSmiles":"CCCCOc1cc(C[C@@H]2CNC(=O)N2)ccc1OC","inchiKey":"PDMUULPVBYQBBK-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229585","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113488"],"drugbank":["DB06842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230191","canonicalSmiles":"O=P(O)(O)OP(=O)(O)OP(=O)(O)O","inchiKey":"UNXRWKVEANCORM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPHOSPHATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Triphosphate"],"crossReferences":{"drugbank":["DB03896"],"chEBI":["39949"]},"childChemblIds":["CHEMBL3183517"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1231358","canonicalSmiles":"Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3ccccc3)C1=N2","inchiKey":"LZAXPYOBKSJSEX-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231358","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26753178","29215123"],"drugbank":["DB01944"],"chEBI":["75388"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231453","canonicalSmiles":"Oc1ccc(C2(c3ccc(O)cc3)CCCCC2)cc1","inchiKey":"SDDLEVPIDBLVHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231453","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208215"],"drugbank":["DB07485"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231871","canonicalSmiles":"O=C=O","inchiKey":"CURLTUGMZLYLDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBON DIOXIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbon Dioxide","Carbon dioxide","E-290","E290","INS NO.290","INS-290","NSC-81688"],"crossReferences":{"Wikipedia":["Carbon_dioxide"],"drugbank":["DB09157"],"chEBI":["16526"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1233882","canonicalSmiles":"CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21","inchiKey":"GEZALMMCQYDFML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233882","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08054"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234086","canonicalSmiles":"CNS(=O)(=O)Cc1ccc(N/N=C2\\C(=O)Nc3ccc4ncsc4c32)cc1","inchiKey":"GEWPSTLKJDIUHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234086","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08123"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234585","canonicalSmiles":"O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2cc1OP(=O)(O)O","inchiKey":"RQAQWBFHPMSXKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234585","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08240"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234916","canonicalSmiles":"CC(=O)OC[C@H](N)C(=O)O","inchiKey":"VZXPDPZARILFQX-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234916","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01837"],"chEBI":["17981"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236441","canonicalSmiles":"CC(=O)n1c2c(c3ccccc31)CCCC2=O","inchiKey":"MIGJEXKBUJPKJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236441","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL124718","canonicalSmiles":"C[C@](O)(COc1ccc(F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1","inchiKey":"KJMFOTCDISOHDX-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL124718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07769"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256708","canonicalSmiles":"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl.O","inchiKey":"DQQCJDBYNZMPOA-FFXKMJQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APOMORPHINE HYDROCHLORIDE HEMIHYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL53","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apomorphine Hydrochloride Hemihydrate"],"crossReferences":{"PubChem":["11533000","56373918","56462998","85273689"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256987","canonicalSmiles":"CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\\CCC=C(C)C)C(=O)[O-].[Na+]","inchiKey":"HJHVQCXHVMGZNC-JCJNLNMISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FUSIDATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL374975","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fucidine"],"synonyms":["Fusidate sodium","Fusidic Acid Sodium","Fusidic acid sodium salt","SQ 16360","SQ-16360","Sodium fusidate","ZN-6"],"crossReferences":{"PubChem":["144204296","57260077"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1257002","canonicalSmiles":"CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1.Cl.Cl","inchiKey":"CXGURXWCQYHDIR-ULPVBNQHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIMELIDINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL37744","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zimelidine Dihydrochloride"],"crossReferences":{"PubChem":["50107236"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330596","canonicalSmiles":"CC(N)(Cc1ccc(O)cc1)C(=O)O","inchiKey":"NHTGHBARYWONDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACEMETYROSINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Racemetirosine","Racemetyrosine","SM-88","SM-88 COMPONENT RACEMETYROSINE"],"crossReferences":{"PubChem":["50105713","90340781"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL135302","canonicalSmiles":"NC(=O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"UKWLGCFJAVEFPE-DVKNGEFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL135302","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL135400","canonicalSmiles":"CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1","inchiKey":"GBBSUAFBMRNDJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOPICLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zileze 3.75","Zileze 7.5","Zimovane","Zimovane ls"],"synonyms":["RP 27267","RP-27267","Zopiclone"],"crossReferences":{"PubChem":["124881861","26747152","866104"],"Wikipedia":["Zopiclone"],"drugbank":["DB01198"],"chEBI":["32315"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL136737","canonicalSmiles":"Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1","inchiKey":"VFEDRRNHLBGPNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIMUSTINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nimustine","Nimustine hydrochloride"],"crossReferences":{"PubChem":["11111557","144203765","170466029","50106657","85231161","90341805"],"drugbank":["DB13069"],"chEBI":["75270"]},"childChemblIds":["CHEMBL1256616"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1477036","canonicalSmiles":"CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O","inchiKey":"HNSDLXPSAYFUHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOCUSATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Docusate"],"crossReferences":{"PubChem":["104171408","29216456"],"Wikipedia":["Dioctyl_sodium_sulfosuccinate"],"drugbank":["DB11089"],"chEBI":["534"]},"childChemblIds":["CHEMBL1905872","CHEMBL2107648","CHEMBL2106608"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1490","canonicalSmiles":"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1","inchiKey":"HWHLPVGTWGOCJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIHEXYPHENIDYL","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-12268","Trihexyphenidyl"],"crossReferences":{"DailyMed":["trihexyphenidyl%20hydrochloride"],"PubChem":["50105266","90341555"],"Wikipedia":["Trihexyphenidyl"],"drugbank":["DB00376"],"chEBI":["9720"]},"childChemblIds":["CHEMBL1092"],"count":2,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["MONDO_0003441","EFO_0002508","EFO_1000632"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and is indicated for parkinson's disease and has 1 investigational indication."}
{"id":"CHEMBL1506","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1","inchiKey":"PXKHGMGELZGJQE-ILBGXUMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAMPHENICOL PALMITATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorolifarina","Chloromycetin palmitate","Chloropal"],"synonyms":["Chloramphenicol Palmitate","Chloramphenicol palmitate"],"crossReferences":{"PubChem":["144206645"],"drugbank":["DB14658"],"chEBI":["3605"]},"count":3,"approvedIndications":["EFO_0000771","EFO_1001888","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 approved indications."}
{"id":"CHEMBL1531","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC","inchiKey":"GCKFUYQCUCGESZ-BPIQYHPVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ETONOGESTREL","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Implanon","Nexplanon"],"synonyms":["Etonogestrel","Implanon","ORG 3236","ORG-3236"],"crossReferences":{"DailyMed":["etonogestrel"],"PubChem":["144206191","50113279"],"Wikipedia":["Etonogestrel"],"drugbank":["DB00294"],"chEBI":["50777"]},"count":4,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000765","Orphanet_232","EFO_0001065","EFO_0000764","HP_0100607","EFO_0003932","EFO_0000284","EFO_0000660"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1578","canonicalSmiles":"CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C.[Br-]","inchiKey":"QSFKGMJOKUZAJM-CNKDKAJDSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISOTROPINE METHYLBROMIDE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1186610","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anisotropine methylbromide","Valpin","Valpin 50"],"synonyms":["Anisotropine methylbromide","Octatropine methylbromide","Octatropone bromide"],"crossReferences":{"PubChem":["144204422","144207024","56422429","855548"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1584","canonicalSmiles":"CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2","inchiKey":"BTFMCMVEUCGQDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERACETAZINE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Quide"],"synonyms":["PC-1421","Piperacetazine"],"crossReferences":{"PubChem":["11112549","144204091","170465363","56463171"],"Wikipedia":["Piperacetazine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969."}
{"id":"CHEMBL160519","canonicalSmiles":"CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12","inchiKey":"FKNXQNWAXFXVNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCATEROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Procaterol"],"childChemblIds":["CHEMBL1322218"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1626","canonicalSmiles":"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1","inchiKey":"YNNUSGIPVFPVBX-NHCUHLMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEMASTINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clemastine","HS-592"],"crossReferences":{"DailyMed":["clemastine%20fumarate"],"PubChem":["11111002","11112618","11114089","124882478","152146162"],"Wikipedia":["Clemastine"],"drugbank":["DB00283"],"chEBI":["3738"]},"childChemblIds":["CHEMBL1200795"],"count":7,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0007405","HP_0000989","EFO_0005531","MONDO_0002406","EFO_0003929","EFO_0005532","EFO_0003785"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for allergy and pruritus and has 5 investigational indications."}
{"id":"CHEMBL165","canonicalSmiles":"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1","inchiKey":"LUKBXSAWLPMMSZ-OWOJBTEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESVERATROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(E)-resveratrol","3,5,4'-Trihydroxy-trans-stilbene","BIA 6-512","BIA-6-512","NSC-327430","Resveratrol"],"crossReferences":{"PubChem":["124883089","124883091","124883093","124883094","144203808","144208572","144213690","170466838","17388746","26747076","26747077","26751586","26751587","458391","49734167","50104223","50104224","50104225","50126366","85231343","855986","90341821"],"Wikipedia":["Resveratrol"],"drugbank":["DB02709"],"chEBI":["45713"]},"count":31,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 31 investigational indications."}
{"id":"CHEMBL1682","canonicalSmiles":"OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"FBPFZTCFMRRESA-JGWLITMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORBITOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["7B5697N","D-sorbitol","E 420","E420","FEMA NO. 3029","Isomalt impurity, sorbitol-","NSC-25944","Sorbitol"],"crossReferences":{"PubChem":["144213700","26757772","56322758"],"Wikipedia":["Sorbitol"],"drugbank":["DB01638"],"chEBI":["17924"]},"count":5,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 4 investigational indications."}
{"id":"CHEMBL168276","canonicalSmiles":"O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1","inchiKey":"VDCDWNDTNSWDFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,5-DINITROCATECHOL (OR-486)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,5-Dinitrocatechol"],"crossReferences":{"PubChem":["11111032","11113526","124879815","124879816","26747113","50104432","56463318","85230992","90341310"],"drugbank":["DB02105"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697737","canonicalSmiles":"CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl","inchiKey":"CHBRHODLKOZEPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOTIAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clozan"],"synonyms":["Clotiazepam"],"crossReferences":{"drugbank":["DB01559"]},"count":1,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0005230"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anxiety."}
{"id":"CHEMBL1697748","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]3NC(C)=O)[C@H](O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"KIUKXJAPPMFGSW-DNGZLQJQSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"HYALURONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hyaluronic Acid","Hyaluronic acid"],"count":3,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1719","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl","inchiKey":"HVRLZEKDTUEKQH-NOILCQHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOPATADINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1189432","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olopatadine hydrochloride","Pataday","Pataday once daily relief","Pataday twice daily relief","Patanase","Patanol","Pazeo"],"synonyms":["ALO-4943A","ALO4943A","KW-4679","KW4679","Olopatadine hydrochloride"],"crossReferences":{"DailyMed":["olopatadine%20hydrochloride"],"PubChem":["144205795","170465181","49681604"]},"count":4,"approvedIndications":["HP_0000989","EFO_0007141"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000989","EFO_0007141","EFO_1001417","EFO_0003956"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for allergic conjunctivitis and pruritus and has 2 investigational indications."}
{"id":"CHEMBL173929","canonicalSmiles":"CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C","inchiKey":"KBPHJBAIARWVSC-RGZFRNHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUTEIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E 161","E-161B","E-161B(I)","E161b","INS NO.161B(I)","INS-161B(I)","Lutein","NSC-59193","Xanthophyll","Xantofyl"],"crossReferences":{"PubChem":["144206147"],"Wikipedia":["Lutein"],"drugbank":["DB00137"],"chEBI":["28838"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1742989","drugType":"Antibody","blackBoxWarning":false,"name":"BAVITUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bavituximab","CH3G4","TARVACIN"],"count":14,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL1788373","canonicalSmiles":"Br.Br.CC[C@@H](CO)NCCN[C@@H](CC)CO","inchiKey":"QKQLJJFOYPGDEX-BZDVOYDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHAMBUTOL HYDROBROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL44884","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ethambutol"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1802037","canonicalSmiles":"O=C(Nc1ccc2[nH]c(=O)oc2c1)C(=O)N1CCC(Cc2ccc([18F])cc2)CC1","inchiKey":"GKGRZLGAQZPEHO-KVTPGWOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1802037","maximumClinicalTrialPhase":0,"parentId":"CHEMBL182066","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1818341","canonicalSmiles":"CC(C)CNCc1ccc(-c2ccccc2S(=O)(=O)N2CCCC2)cc1","inchiKey":"OWVIKBRKPCTDEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04455242","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04455242","Pf-04455242"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL188462","canonicalSmiles":"CN[C@@H](C)C/C=C/c1cncc(OC(C)C)c1","inchiKey":"RPCVIAXDAUMJJP-PZBABLGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISPRONICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3480","Azd3480","Ispronicline","TC-01734","TC-1734"],"count":4,"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0001072","EFO_0000249","EFO_0000692"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1909072","canonicalSmiles":"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"OSJJYEUEJRVVOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPAMAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Pipamazine"],"crossReferences":{"Wikipedia":["Pipamazine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL193264","canonicalSmiles":"O=C(Nc1ccc2ccn(CCc3ccncc3)c2c1)c1cc(F)cc(N2CCOCC2)c1","inchiKey":"CPFBZMFUCGHBAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL193264","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08730"],"chEBI":["46552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200238","canonicalSmiles":"O=C(O)c1ccc(-c2ccccc2Cl)o1","inchiKey":"PJGGWIHXGHQXMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200238","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26514034","29215062","3711134"],"drugbank":["DB02909"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2046550","canonicalSmiles":"C/C(=C(/OCCOc1ccc(Cl)cc1)c1ccc(Cl)cc1Cl)n1ccnc1","inchiKey":"JMFOSJNGKJCTMJ-ZHZULCJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMOCONAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omoconazole"],"crossReferences":{"PubChem":["170465847"],"drugbank":["DB13684"]},"childChemblIds":["CHEMBL2107140"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2062154","canonicalSmiles":"C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)NC[C@H](NC(=O)CCC(=O)O)c1ccccc1","inchiKey":"FVQSSYMRZKLFDR-QRCSZXLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CI-988","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ci-988","PD-134308"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2088033","canonicalSmiles":"CNC(=O)[C@@H](Cc1ccccc1F)CN1CCC2(CC1)OCCc1cc(F)sc12","inchiKey":"MZBCQWLYUQJXKA-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOP-1A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nop-1a"],"crossReferences":{"drugbank":["DB15208"]},"childChemblIds":["CHEMBL2204352"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2095223","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O","inchiKey":"OJPWHUOVKVKBQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE SULPHATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chloroquine sulfate","Chloroquine sulphate","NSC-292296"],"crossReferences":{"chEBI":["50178"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2103822","canonicalSmiles":"CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2","inchiKey":"PTOIAAWZLUQTIO-GXFFZTMASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TASIMELTEON","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hetlioz"],"synonyms":["BMS-214,778","BMS-214778","Tasimelteon","VEC-162"],"crossReferences":{"DailyMed":["tasimelteon"],"drugbank":["DB09071"],"chEBI":["79042"]},"count":7,"linkedTargets":{"rows":["ENSG00000168412","ENSG00000134640"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0002009","MONDO_0003406","EFO_0001421","Orphanet_819","MONDO_0024361","EFO_0004698"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 7 investigational indications."}
{"id":"CHEMBL2105646","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C","inchiKey":"ORFLZNAGUTZRLQ-ZMBVWFSWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LARAZOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-2347","Larazotide"],"crossReferences":{"drugbank":["DB05645"]},"childChemblIds":["CHEMBL2103815"],"count":1,"linkedTargets":{"rows":["ENSG00000080644","ENSG00000117971"],"count":2},"linkedDiseases":{"rows":["EFO_0001060"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105708","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl","inchiKey":"BWTNNZPNKQIADY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PONATINIB HYDROCHLORIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1171837","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iclusig"],"synonyms":["AP-24534 HCL","AP24534 HCL","Ponatinib hydrochloride"],"crossReferences":{"DailyMed":["ponatinib%20hydrochloride"]},"count":5,"approvedIndications":["EFO_0000339","EFO_0000220"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0000339","EFO_0000220","EFO_1000131","EFO_0000222","EFO_0008550","MONDO_0003541","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for chronic myelogenous leukemia and acute lymphoblastic leukemia and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105755","canonicalSmiles":"CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)c1nc(-c2ccccc2)no1","inchiKey":"AXQACEQYCPKDMV-RZAWKFBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALDEMEDINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Naldemedine","S-297995"],"crossReferences":{"DailyMed":["naldemedine%20tosylate"],"drugbank":["DB11691"]},"childChemblIds":["CHEMBL3039508"],"count":1,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0004880","HP_0002019"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for constipation."}
{"id":"CHEMBL2106085","canonicalSmiles":"O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+]","inchiKey":"ULEUKTXFAJZAAV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORAZEPATE MONOPOTASSIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1213252","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4311 CB","ABBOTT-39083","Clorazepate monopotassium","Potassium clorazepate"],"crossReferences":{"chEBI":["59591"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106155","canonicalSmiles":"COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1.Cl","inchiKey":"OJIIZIWOLTYOBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCAINIDE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL315838","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Cardiotoxicity"],"year":1991},"tradeNames":["Enkaid"],"synonyms":["Encainide hydrochloride","MJ 9067-1"],"crossReferences":{"PubChem":["144207047"],"chEBI":["59880"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986. It was withdrawn in United Kingdom and  United States initially in 1991 due to Cardiotoxicity."}
{"id":"CHEMBL2106794","canonicalSmiles":"NC(=O)N/N=C1\\C=Cc2ccccc2C1=O","inchiKey":"TZGBBMBARSFJBG-UKTHLTGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFTAZONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mediavan"],"synonyms":["Naftazone"],"crossReferences":{"drugbank":["DB13680"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL2107313","canonicalSmiles":"CCN(CC)CCN1C(=O)c2c(c3c4cccc(Cl)c4n([C@@H]4O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]4O)c3c3[nH]c4c(Cl)cccc4c23)C1=O","inchiKey":"JSKFWUPVIZYJMR-UDOAKELVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECATECARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-181176","BMY-27557","Becatecarin","NSC-655649","XL-119","XL119 "],"crossReferences":{"drugbank":["DB06362"]},"count":10,"linkedTargets":{"rows":["ENSG00000131747","ENSG00000198900","ENSG00000077097"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0003060","EFO_0006861","MONDO_0008170","MONDO_0008903","MONDO_0000956","EFO_0000702","EFO_0000574","MONDO_0002367","EFO_0000621","EFO_1001951"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2107320","canonicalSmiles":"CC(=O)N1CCN([C@H]2CCN(C(=O)N(C)[C@H](C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1.CS(=O)(=O)O","inchiKey":"YRFKYVWDPCOSTE-REWBLLDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASOPITANT MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1672054","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Casopitant mesylate","GW679769B"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107334","canonicalSmiles":"CC(C)(C)[N+]([O-])=Cc1ccc(S(=O)(=O)[O-])cc1S(=O)(=O)[O-].[Na+].[Na+]","inchiKey":"XLZOVRYBVCMCGL-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DISUFENTON SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111090","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Disufenton sodium","Disufenton sodium salt","NXY-059","OKN-007"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107349","canonicalSmiles":"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1.Cl","inchiKey":"GXYZREDEYDFJPT-ZMBIFBSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LECOZOTAN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL372205","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lecozotan hydrochloride","SRA-333"],"count":1,"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107797","canonicalSmiles":"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC","inchiKey":"WWYNJERNGUHSAO-CULCCENASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORGESTREL","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Opill","Ovrette"],"synonyms":["Norgestrel","Prefest","Previfem","Sprintec","Tri-Previfem","Tri-Sprintec","WY-3707"],"crossReferences":{"DailyMed":["norgestrel"],"PubChem":["144213928"]},"count":1,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MONDO_0011962"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1968 and has 1 investigational indication."}
{"id":"CHEMBL2107822","canonicalSmiles":"Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1","inchiKey":"NPFDWHQSDBWQLH-QZTJIDSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILOREXANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Filorexant","MK-6096"],"crossReferences":{"drugbank":["DB12158"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107862","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"RINTATOLIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ampligen"],"synonyms":["Rintatolimod"],"count":9,"linkedTargets":{"rows":["ENSG00000164342"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","MONDO_0004658","EFO_0001423","EFO_0006861","MONDO_0015686","EFO_0000756","MONDO_0008170","EFO_0000764","MONDO_0007254","EFO_0000673","EFO_0004540"],"count":11},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2107874","drugType":"Antibody","blackBoxWarning":true,"name":"ROMOSOZUMAB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evenity"],"synonyms":["AMG 785","AMG-785","CDP-7851","CDP7851","Romosozumab","Romosozumab-aqqg"],"crossReferences":{"DailyMed":["romosozumab-aqqg"]},"count":5,"approvedIndications":["EFO_0003854","EFO_0004260"],"linkedTargets":{"rows":["ENSG00000167941"],"count":1},"linkedDiseases":{"rows":["HP_0000938","EFO_0003931","EFO_0003854","EFO_0004260","Orphanet_666","EFO_0003882"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for postmenopausal osteoporosis and bone disease and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108131","drugType":"Unknown","blackBoxWarning":false,"name":"PLASMINOGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plasminogen","Profibrinolysin"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108308","drugType":"Protein","blackBoxWarning":false,"name":"TERTOMOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GV-1001","GV1001","Gv1001","Tertomotide"],"count":6,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2108311","drugType":"Enzyme","blackBoxWarning":false,"name":"ASFOTASE ALFA","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Strensiq"],"synonyms":["ALXN-1215","ALXN1215","Asfotase alfa","ENB-0040"],"crossReferences":{"DailyMed":["asfotase%20alfa"],"DrugCentral":["5049"]},"count":3,"approvedIndications":["Orphanet_436"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for hypophosphatasia and has 2 investigational indications."}
{"id":"CHEMBL2108455","drugType":"Protein","blackBoxWarning":false,"name":"OCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octocog alfa"],"crossReferences":{"DrugCentral":["5099"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108723","drugType":"Protein","blackBoxWarning":false,"name":"PEGINTERFERON LAMBDA-1A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-914143","PEG-IL-29","PEG-RIL-29","PEG-RLL-29","Peginterferon lambda-1a"],"count":5,"linkedTargets":{"rows":["ENSG00000185436","ENSG00000243646"],"count":2},"linkedDiseases":{"rows":["EFO_0004220","MONDO_0100096","EFO_0004197","EFO_0003047","EFO_0007304","EFO_0004239"],"count":6},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108747","drugType":"Antibody","blackBoxWarning":false,"name":"TORALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-CD154","ANTI-CD40L","ANTI-GP39","E-6040","IDEC-131","Toralizumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108964","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN, ISOPHANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ins hum insulat","Ins hum protaphane","Ins humulin i","Ins hypurin bov isop","Ins hypurin pore isop","Ins innolet insulat","Ins insulat","Ins insulat novolet","Ins insuman basal","Ins insuman basal optiset","Ins insuman basal solostar","Ins novolet hum protaphane","Ins pork insulat","Ins pur-in hum isop","Nph iletin","Penfill"],"synonyms":["Insulin injection","Insulin, isophane","Isophane (aqueous suspension)","Isophane insulin"],"count":4,"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109267","drugType":"Antibody","blackBoxWarning":false,"name":"M195","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M195"],"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198","EFO_0004251"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109288","drugType":"Antibody","blackBoxWarning":false,"name":"BIVATUZUMAB MERTANSINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIWA-1-DM1","Bivatuzumab mertansine"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109526","drugType":"Antibody","blackBoxWarning":false,"name":"PG-110","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PG-110","Pg-110"],"count":1,"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["EFO_0004616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109667","drugType":"Antibody","blackBoxWarning":false,"name":"SIMTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB-0024","AB0024","GS-6624","Simtuzumab"],"count":7,"linkedTargets":{"rows":["ENSG00000134013"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0001422","EFO_0000616","MONDO_0044903","EFO_0004268","EFO_0000768","EFO_1001951"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109678","drugType":"Antibody","blackBoxWarning":false,"name":"HUJ591 177LU","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUJ591","Huj591 (177lu)","Huj591 177lu"],"count":1,"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110730","canonicalSmiles":"CSCC[C@H](N)C(=O)N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21","inchiKey":"VOYCNOJFAJAILW-CAMHOICYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POMAGLUMETAD METHIONIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2140023","LY-2140023 MONOHYDRATE","LY2140023","Ly2140023","Pomaglumetad methionil"],"childChemblIds":["CHEMBL2105707"],"count":4,"linkedTargets":{"rows":["ENSG00000164082","ENSG00000198822"],"count":2},"linkedDiseases":{"rows":["EFO_0005407","EFO_0001358","EFO_0004701","EFO_0000692"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2110780","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(NC(N)=O)c1","inchiKey":"KEMXXQOFIRIICG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBUTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbuterol"],"crossReferences":{"drugbank":["DB13625"]},"childChemblIds":["CHEMBL2106022"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110857","canonicalSmiles":"Cn1nc(CO)nc1NCCCOc1cccc(CN2CCCCC2)c1","inchiKey":"VTLNPNNUIJHJQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAVOLTIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AH-23844 FREE BASE","Lavoltidine"],"crossReferences":{"drugbank":["DB12884"],"chEBI":["6550"]},"childChemblIds":["CHEMBL3989590"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2113354","canonicalSmiles":"Cl.Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1","inchiKey":"SFWYWKVSAHDQRB-HBYDGSNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2113354","maximumClinicalTrialPhase":0,"parentId":"CHEMBL328190","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2130595","canonicalSmiles":"NC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"ACFZEFCGESJKJH-JZGIKJSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2130595","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1437","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205193","170465227"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL218427","canonicalSmiles":"Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCOCC4)c3Cl)c2n1","inchiKey":"FQVSDHOWSLEEKJ-LJAQVGFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FASITIBANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasitibant","MEN-16132","MEN-16132 FREE BASE"],"crossReferences":{"drugbank":["DB15646"]},"childChemblIds":["CHEMBL541758"],"count":2,"linkedTargets":{"rows":["ENSG00000168398"],"count":1},"linkedDiseases":{"rows":["EFO_0002506","EFO_0004616"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL220513","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2n[nH]c(-c3ccc(Cl)s3)n2)C1=O","inchiKey":"FKCQUVAGEOSYRU-QWRGUYRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220513","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07804"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221326","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"NMLMACJWHPHKGR-NCOIDOBVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIQUAFOSOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diquafosol","INS-365"],"crossReferences":{"Wikipedia":["Diquafosol"],"chEBI":["27791"]},"childChemblIds":["CHEMBL1767408"],"linkedTargets":{"rows":["ENSG00000186912","ENSG00000169860","ENSG00000175591","ENSG00000171631"],"count":4},"linkedDiseases":{"rows":["EFO_1000906"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL227381","canonicalSmiles":"O=S(=O)(NCCNCCOCc1ccc(Cl)cc1)c1cccc2cnccc12","inchiKey":"AUHWQSZMVMMRLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07947"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2348292","canonicalSmiles":"O=C(O)CCc1cc(I)c(Oc2ccc(O)cc2)c(I)c1","inchiKey":"WONYMNWUJVKVII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,5-DIIODOTHYROPROPIONIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,5-diiodothyropropionic acid","Ditpa"],"crossReferences":{"drugbank":["DB12629"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2361014","canonicalSmiles":"CC(=O)OC1(c2ccccc2)CCN(CCc2ccccc2)CC1","inchiKey":"BVURVTVDNWSNFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2361014","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206386"],"drugbank":["DB01562"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24441","canonicalSmiles":"CNCCc1ccccn1","inchiKey":"UUQMNUMQCIQDMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAHISTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betahistine"],"crossReferences":{"Wikipedia":["Betahistine"],"drugbank":["DB06698"],"chEBI":["35677"]},"childChemblIds":["CHEMBL4303472","CHEMBL1451277","CHEMBL1446813","CHEMBL1464589"],"count":5,"approvedIndications":["HP_0002321"],"linkedTargets":{"rows":["ENSG00000101180","ENSG00000196639"],"count":2},"linkedDiseases":{"rows":["EFO_0006862","EFO_0003888","EFO_0004566","HP_0003124","MONDO_0002009","HP_0002321","EFO_0001073"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for vertigo and has 4 investigational indications."}
{"id":"CHEMBL278020","canonicalSmiles":"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1","inchiKey":"ALWKGYPQUAPLQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEOSTIGMINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Neostigmine"],"crossReferences":{"DailyMed":["neostigmine%20methylsulfate"],"PubChem":["11111527","11111528","26756597","90340848"],"drugbank":["DB01400"],"chEBI":["7514"]},"childChemblIds":["CHEMBL211471","CHEMBL54126"],"count":7,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0001074","EFO_0004210","HP_0002093","EFO_0005323","EFO_0001645","MONDO_0004567","MONDO_0007254","EFO_0009516","EFO_0009267","EFO_0001073","EFO_0003843","HP_0002315","EFO_0002950","MONDO_0001187","EFO_0001422","EFO_0004888","EFO_0004209","EFO_0000341","EFO_0004991","EFO_0000516","HP_0003270","EFO_0003918","HP_0025267","GO_0007596","HP_0003470"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for glaucoma and has 6 investigational indications."}
{"id":"CHEMBL278785","canonicalSmiles":"O=C(O)[C@H](Cc1ccccc1)N(Cc1ccc(-c2cc3ccccc3o2)s1)C(=O)c1ccc(Cl)cc1Cl","inchiKey":"YBULOUKTPCHXAL-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL278785","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL281948","canonicalSmiles":"COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4","inchiKey":"KOZFSFOOLUUIGY-SOLYNIJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"K-252A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K-252A"],"crossReferences":{"Wikipedia":["K252a"],"drugbank":["DB02152"],"chEBI":["43616"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284314","canonicalSmiles":"C=CCN1C(=O)N(CC=C)[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@H]1Cc1ccccc1","inchiKey":"IWJSQELMWLOYSO-LWSSLDFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL284314","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06910"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL294951","canonicalSmiles":"CN1CCC(=C2c3ccccc3CCc3sccc32)CC1","inchiKey":"FIADGNVRKBPQEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIZOTYLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sandomigran"],"synonyms":["BC-105","Pizotifen","Pizotyline"],"crossReferences":{"PubChem":["124892409","144205577","170466311","26756535"],"Wikipedia":["Pizotifen"],"drugbank":["DB06153"],"chEBI":["50212"]},"childChemblIds":["CHEMBL1592663","CHEMBL1707025","CHEMBL1512796","CHEMBL1326119"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3039505","canonicalSmiles":"CC(C)(C)c1ccc(S(=O)(=O)[N-]c2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1.[Na+]","inchiKey":"RWWYDQSZJIFTES-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"VERCIRNON SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2178578","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1605786A","GSK1605786A","Vercirnon sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3140370","canonicalSmiles":"CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1.Cl.Cl","inchiKey":"HHPSICLSNHCSNZ-BYEGLACWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIMILIDE DIHYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL123558","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azimilide dihydrochloride","Azimilide hydrochloride","NE-10064"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3183409","canonicalSmiles":"CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F","inchiKey":"HJBWBFZLDZWPHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APALUTAMIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erleada"],"synonyms":["ARN-509","Apalutamide","Arn-509","JNJ-56021927"],"crossReferences":{"DailyMed":["apalutamide"],"PubChem":["174007290"],"drugbank":["DB11901"]},"childChemblIds":["CHEMBL4082191","CHEMBL4105484","CHEMBL4100200","CHEMBL4062002"],"count":7,"approvedIndications":["EFO_0000616","MONDO_0008315","EFO_0001663"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003826","EFO_0001421","EFO_0000673","EFO_0000196","MONDO_0008315","EFO_0001663"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL3183549","canonicalSmiles":"CC(=C(CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N","inchiKey":"BTNNPSLJPBRMLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENFOTIAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8088 C.B","8088 C.B.","8088-CB","8088CB","Benfotiamine","Benzoylthiaminmonophosphat"],"crossReferences":{"PubChem":["144204148","170465987"],"chEBI":["41039"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3185958","canonicalSmiles":"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"PYTMYKVIJXPNBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMIPHENE CITRATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2355051","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clomid","Clomiphene citrate","Clophene","Milophene","Serophene"],"synonyms":["Chloramiphene","Clomid","Clomifene citrate","Clomiphene citrate","MER-41","MRL-41","NSC-35770"],"crossReferences":{"DailyMed":["clomiphene%20citrate"],"PubChem":["144212192"],"chEBI":["3753"]},"count":3,"approvedIndications":["EFO_0000545"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0008560","MONDO_0002775","EFO_0000660"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for infertility and has 2 investigational indications."}
{"id":"CHEMBL325023","canonicalSmiles":"Cc1nc(C)c(-c2[nH]nc3c2C(=O)c2c(NC(=O)NN4CCN(C)CC4)cccc2-3)s1","inchiKey":"KRKQVGZXTNLQSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL325023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07622"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3304484","canonicalSmiles":"CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC.CCCCCCCC(=O)OCC(O)CO.CCCCCCCCCC(=O)OCC(O)CO","inchiKey":"JFUMHQVCWWFATH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOCTANOIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3301678"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL3351077","canonicalSmiles":"NC(=O)c1cc[n+](CC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)[O-])[C@H]3SC2)cc1","inchiKey":"SYLKGLMBLAAGSC-QLVMHMETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFSULODIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefsulodin"],"crossReferences":{"drugbank":["DB13499"],"chEBI":["3507"]},"childChemblIds":["CHEMBL1590946","CHEMBL4303721"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL3544909","canonicalSmiles":"C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O.O","inchiKey":"WRLFSJXJGJBFJQ-WPUCQFJDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIFEDIOL","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1040","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calderol","Rayaldee"],"synonyms":["CTAP101","Calcidiol","Calcifediol","U-32,070E","U-32070E"],"count":5,"approvedIndications":["EFO_1001173"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","MONDO_0100096","HP_0002024","EFO_0000270","HP_0001919","EFO_0003762","EFO_0000612","EFO_0003918"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for secondary hyperparathyroidism and has 4 investigational indications."}
{"id":"CHEMBL3545208","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD3161","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd3161"],"count":1,"linkedTargets":{"rows":["ENSG00000169432"],"count":1},"linkedDiseases":{"rows":["EFO_0005762"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545214","drugType":"Small molecule","blackBoxWarning":false,"name":"AXP-107-11","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axp-107-11"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545221","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD2423","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd2423"],"count":3,"linkedTargets":{"rows":["ENSG00000121807"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000341","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL357452","canonicalSmiles":"O=C1OCc2c(Cl)c(Cl)c(Cl)c(Cl)c21","inchiKey":"NMWKWBPNKPGATC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4,5,6,7-TETRACHLOROPHTHALIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03302"],"chEBI":["47617"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL370252","canonicalSmiles":"CC1CCc2cc(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"DPSPPJIUMHPXMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMEQUINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flumequine"],"crossReferences":{"PubChem":["104171372","144204391","170466145","26747215","56423139","856003"],"drugbank":["DB08972"],"chEBI":["85269"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL371064","canonicalSmiles":"CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1","inchiKey":"LLCRBOWRJOUJAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALICATIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AAE-581","AAE581","Balicatib"],"crossReferences":{"drugbank":["DB12239"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL372303","canonicalSmiles":"CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1","inchiKey":"UYJZZVDLGDDTCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PJ34","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08348"]},"childChemblIds":["CHEMBL3233481","CHEMBL4161122"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379642","canonicalSmiles":"O=C(Sc1nnc(C(F)(F)F)[nH]1)c1ccc(C#Cc2ccccc2)o1","inchiKey":"VNGWUVBXUIDQTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379642","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07743"],"chEBI":["42403"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL381806","canonicalSmiles":"NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)C[C@H](N)Cc1ccccc1F","inchiKey":"OEVYDSSAPNIURZ-AEFFLSMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL381806","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04578"],"chEBI":["39484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382311","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc([C@@H]2CC(=O)NS2(=O)=O)cc1)C(N)=O","inchiKey":"UILYPHAKDBTKQV-UFYCRDLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL382311","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833377","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Zn+2]","inchiKey":"WHMDKBIGKVEYHS-IYEMJOQQSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC GLUCONATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gluconic acid zinc complex","Zinc gluconate"],"crossReferences":{"DrugCentral":["4343"],"drugbank":["DB11248"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3930624","canonicalSmiles":"O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCn2nc(C(F)(F)F)nc2C1","inchiKey":"XJGXCBHXFWBOTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUZOPARIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluzoparib","SHR-3162","SHR3162","Shr3162"],"crossReferences":{"drugbank":["DB15637"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3967390","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1[125I]","inchiKey":"XQFRJNBWHJMXHO-XCAQJPMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3967390","maximumClinicalTrialPhase":0,"parentId":"CHEMBL788","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989519","canonicalSmiles":"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl.O","inchiKey":"ZOMBFZRWMLIDPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXAPRAM HYDROCHLORIDE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1754","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dopram","Doxapram hydrochloride","Stimulexin"],"synonyms":["AHR-619","Doxapram hydrochloride","Doxapram hydrochloride hydrate","Doxapram hydrochloride monohydrate","NSC-170958"],"crossReferences":{"DailyMed":["doxapram%20hydrochloride"]},"count":1,"linkedTargets":{"rows":["ENSG00000169427","ENSG00000171303"],"count":2},"linkedDiseases":{"rows":["EFO_0009444","EFO_0004262","EFO_0003917","HP_0002104"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1965 and has 1 investigational indication."}
{"id":"CHEMBL3989921","canonicalSmiles":"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\\C(=O)O","inchiKey":"VXZCUHNJXSIJIM-MEBGWEOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERATINIB MALEATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL180022","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nerlynx"],"synonyms":["Neratinib maleate"],"crossReferences":{"DailyMed":["neratinib%20maleate"]},"count":1,"approvedIndications":["EFO_0000305"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0000305"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for breast carcinoma."}
{"id":"CHEMBL3989946","canonicalSmiles":"Br.O.[2H]C([2H])([2H])Oc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C([2H])([2H])[2H])CC3","inchiKey":"STTADZBLEUMJRG-CDZAPMPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEUDEXTROMETHORPHAN HYDROBROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL52440","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deudextromethorphan hydrobromide","d6-DM hydrobromide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989970","canonicalSmiles":"C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F","inchiKey":"JYIUNVOCEFIUIU-GHMZBOCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAVELERTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mavelertinib","PF-06747775"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990039","drugType":"Antibody","blackBoxWarning":false,"name":"MARSTACIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Marstacimab","PF-06741086"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3990694","canonicalSmiles":"C1CNCCN1.C1CNCCN1.C1CNCCN1.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"JDDHUROHDHPVIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAZINE CITRATE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antepar","Bryrel","Multifuge","Piperazine citrate","Vermidol"],"synonyms":["Piperazine citrate"],"childChemblIds":["CHEMBL3989678"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954."}
{"id":"CHEMBL4061538","canonicalSmiles":"Cl.Cl.N[C@@H](Cc1ccc([N+]([O-])(CCCl)CCCl)cc1)C(=O)O","inchiKey":"GIGCDIVNDFQKRA-LTCKWSDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4061538","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4117516","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06082"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL410462","canonicalSmiles":"COC(=O)[C@@]1(Cc2ccc(OCc3cc(C)nc4ccccc34)cc2)C[C@@H]1C(=O)NO","inchiKey":"HJWMYFBKJRVWJY-YKSBVNFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL410462","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07147"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4113131","canonicalSmiles":"C[C@H]1CN(C(=O)c2ccc(NC(=O)c3cc(O[C@H](C)c4c(Cl)ccc(F)c4Cl)c(N)nn3)cc2)C[C@@H](C)N1","inchiKey":"GLYMPHUVMRFTFV-QLFBSQMISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENSARTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensartinib","X-396"],"crossReferences":{"drugbank":["DB14860"]},"childChemblIds":["CHEMBL4297219"],"count":3,"linkedTargets":{"rows":["ENSG00000171094"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","MONDO_0008903","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL42403","canonicalSmiles":"OB(O)O","inchiKey":"KGBXLFKZBHKPEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BORIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Boracic acid","Boric Acid","Boric acid","E-284","E284","INS NO.284","INS-284","NSC-81726"],"crossReferences":{"PubChem":["144204555","144209383","144211317","17390008","26752774"],"Wikipedia":["Boric_acid"],"drugbank":["DB11326"],"chEBI":["33118"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297190","canonicalSmiles":"Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1","inchiKey":"TTZSNFLLYPYKIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SURUFATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hmpl-012","Sulfatinib","Surufatinib"],"crossReferences":{"drugbank":["DB15106"]},"count":4,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000077782","ENSG00000037280"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0003060","MONDO_0002108","EFO_1001901","EFO_0002892","EFO_1001951"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297404","canonicalSmiles":"COc1ccc(CC2OC(=O)NC2=O)cc1C(=O)NCc1ccc(C(F)(F)F)cc1","inchiKey":"ORZMUVMQJPGFOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0767","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK 0767","Mk-0767","Mk0767"],"crossReferences":{"drugbank":["DB12055"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297408","canonicalSmiles":"CC[C@@H]1SC2(CCN(C)CC2)NC1=O","inchiKey":"PHOZOHFUXHPOCK-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NGX-267","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF-267B","NGX267","Ngx-267","Ngx267"],"crossReferences":{"drugbank":["DB05152"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297463","canonicalSmiles":"COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCN(CC(F)(F)F)CC2)c2ccccc12","inchiKey":"HPODOLXTMDHLLC-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CPI-1205","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPI-1205","Cpi-1205"],"crossReferences":{"drugbank":["DB14581"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297479","canonicalSmiles":"C[C@@H](O)c1nnc([C@H]2C[C@H](NC(=O)c3cc(-c4ccccc4)no3)C2)o1","inchiKey":"XPEHHUISIBFLHX-RAIGVLPGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NESOLICAFTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nesolicaftor","PTI-428","Pti-428"],"crossReferences":{"drugbank":["DB15239"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297509","canonicalSmiles":"CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1","inchiKey":"SIFNOOUKXBRGGB-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELACESTRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ER-306323","Elacestrant","RAD-1901","RAD1901","Rad1901"],"crossReferences":{"drugbank":["DB06374"]},"childChemblIds":["CHEMBL4594273"],"count":2,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","HP_0031217"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297654","canonicalSmiles":"N=C(N)NC(=N)N","inchiKey":"XNCOSPRUTUOJCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIGUANIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biguanide"],"crossReferences":{"drugbank":["DB13100"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297847","drugType":"Unknown","blackBoxWarning":false,"name":"VGX-100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vgx-100"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297974","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN EEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcitonin eel","HC-58","Hc-58"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297992","drugType":"Unknown","blackBoxWarning":false,"name":"IMGN-779","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMGN-779","IMGN779","Imgn-779","Imgn779"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298079","drugType":"Unknown","blackBoxWarning":false,"name":"SEPHB4-HSA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Recombinant ephb4-hsa fusion protein","Sephb4-hsa"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298171","canonicalSmiles":"COc1cc(F)c(-n2c(=O)[nH]c3csc(C(=O)[O-])c3c2=O)cc1OCc1c(OC)ccc(F)c1F.C[N+](C)(C)CCO","inchiKey":"IAIVRTFCYOGNBW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"LINZAGOLIX CHOLINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3668014","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KLH-2109 choline","Linzagolix choline","OBE2109 choline"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4298207","drugType":"Protein","blackBoxWarning":false,"name":"ZILUCOPLAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RA101495","Zilucoplan"],"count":3,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4303216","canonicalSmiles":"CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O.O","inchiKey":"TUNUVJALSUOKOC-VPJFHDDISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303216","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1397","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL430639","canonicalSmiles":"Cc1cccc([C@]23SCCN2C(=O)c2ccccc23)c1","inchiKey":"FQVDJZWFSZSGGA-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL430639","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07472"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL442720","canonicalSmiles":"CS(=O)(=O)CC[C@H](N)C(=O)O","inchiKey":"UCUNFLYVYCGDHP-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIONINE SULFONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Methionine Sulfone"],"crossReferences":{"drugbank":["DB03790"],"chEBI":["21363"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445001","canonicalSmiles":"C[C@@H]([C@H](O)c1ccccc1)N(C)C","inchiKey":"FMCGSUUBYTWNDP-ONGXEEELSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205074"],"drugbank":["DB11278"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL450613","canonicalSmiles":"C[C@H]1CCC[C@H](O)CCCCCc2cc(O)cc(O)c2C(=O)O1","inchiKey":"DWTTZBARDOXEAM-GXTWGEPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZERANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ralabol","Ralgro"],"synonyms":["MK-188","P-1496","THFES (HM)","Zeranol"],"crossReferences":{"PubChem":["144204524","144208401","17389521","3715954","49674197"],"drugbank":["DB11478"],"chEBI":["35064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459170","canonicalSmiles":"Cc1cc(C#N)cc(Oc2ccc(Cc3n[nH]c4nnccc34)cc2Br)c1","inchiKey":"YYGZQXRLQMFHDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL459170","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08444"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594284","drugType":"Small molecule","blackBoxWarning":false,"name":"PADELIPORFIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tookad"],"synonyms":["Padeliporfin","WST-11","WST11","Wst11"],"count":4,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 3 investigational indications."}
{"id":"CHEMBL4594351","canonicalSmiles":"Cc1c(Cc2ccc(-n3cccn3)cc2)cc2c(c1F)CN([C@H]1COCC[C@@H]1O)C2=O","inchiKey":"WFSARWQASFQZMG-VXKWHMMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-071","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-071"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594362","drugType":"Unknown","blackBoxWarning":false,"name":"SAPOSIN C (NON-GLYCOSYLATED)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BXQ-350","Bxq-350","Saposin c (non-glycosylated)"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594388","drugType":"Antibody","blackBoxWarning":false,"name":"ANSUVIMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ansuvimab","EboV mAb114","MAB114","VRC-EBOMAB092-00-AB"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL460741","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]2O)c(=O)[nH]1","inchiKey":"FOGRQMPFHUHIGU-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Uridine 3'-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Uridine 3'-Phosphate"],"crossReferences":{"drugbank":["DB02714"],"chEBI":["28895"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL471638","canonicalSmiles":"CCCC(CCC)C(=O)NCC(N)=O","inchiKey":"RALGCAOVRLYSMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALROCEMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TV-1901","Valrocemide"],"crossReferences":{"drugbank":["DB06657"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL48813","canonicalSmiles":"N=C(N)c1ccc(CN2CCN(S(=O)(=O)c3cc4ccc(Cl)cc4s3)CC2=O)cc1","inchiKey":"VXONTEUOQXFJJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL48813","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL498416","canonicalSmiles":"Nc1ccccc1C(=O)C[C@H](N)C(=O)O","inchiKey":"YGPSJZOEDVAXAB-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-KYNURENINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-kynurenine"],"crossReferences":{"PubChem":["26756700"],"Wikipedia":["Kynurenine"],"drugbank":["DB02070"],"chEBI":["16946"]},"childChemblIds":["CHEMBL1732584"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL501515","canonicalSmiles":"CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C","inchiKey":"GZYPWOGIYAIIPV-JBDTYSNRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINSENOSIDE RB1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ginsenoside Rb1"],"crossReferences":{"drugbank":["DB06749"],"chEBI":["67989"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL507048","canonicalSmiles":"CCC(C)CCCCC(=O)NCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC1=O","inchiKey":"RPABDKTXMKOGKI-OYTUFZPASA-N","drugType":"Protein","blackBoxWarning":false,"name":"COLIMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Colimycin","Colistimethate sodium","Colistin sodium methanesulfonate","W 1929","W-1929"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL509064","canonicalSmiles":"O=C(O)CNC(=O)c1ncc2c(I)cccc2c1O","inchiKey":"FUMNLXHPILGSLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL509064","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07112"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL52939","canonicalSmiles":"COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1","inchiKey":"FFYNAVGJSYHHFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARPOGRELATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sarpogrelate","Sarpogrelate hydrochloride"],"crossReferences":{"PubChem":["124893325","174006666","50112742"],"drugbank":["DB12163"]},"childChemblIds":["CHEMBL541829"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL554496","canonicalSmiles":"CCOc1ccc(-c2c(C#N)c(N)nc3sc(C(N)=O)c(N)c23)cc1","inchiKey":"UOPQHPBCVYHSFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL554496","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL558598","canonicalSmiles":"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1.Cl","inchiKey":"REOYOKXLUFHOBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMONABANT HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL111","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-141716A"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561564","canonicalSmiles":"CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2.Cl","inchiKey":"JCAUKKAZBDLHNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561564","maximumClinicalTrialPhase":0,"parentId":"CHEMBL564829","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566534","canonicalSmiles":"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3","inchiKey":"SXYIRMFQILZOAM-HVNFFKDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEMETHER","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artemetheri"],"synonyms":["Artemether","Dihydroartemisinin impurity g","NSC-665970","SM 224"],"crossReferences":{"DailyMed":["artemether"],"PubChem":["124893169","26758013"],"drugbank":["DB06697"],"chEBI":["195280"]},"count":6,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for malaria and has 5 investigational indications."}
{"id":"CHEMBL57053","canonicalSmiles":"Oc1ccc(Cl)cc1","inchiKey":"WXNZTHHGJRFXKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARACHLOROPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Parachlorophenol"],"crossReferences":{"PubChem":["144204579","144208902","144213177","170465673","17389609","85272562"],"drugbank":["DB13154"],"chEBI":["28078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL605525","canonicalSmiles":"C=C1[C@H](O)CC(=C/C=C2\\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CCCC(C)(C)O)C[C@H]1O","inchiKey":"UHMPCVGLSKFXHR-NAQZCRMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DP001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2MD","Dp001"],"count":3,"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0003854","EFO_0003882"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL62193","canonicalSmiles":"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1","inchiKey":"ZZORFUFYDOWNEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIMETHOXINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Madribon"],"synonyms":["Sulfadimethoxine","Sulphadimethoxine"],"crossReferences":{"PubChem":["11112268","144203956","170465690","26747078","56424126","855993"],"Wikipedia":["Sulfadimethoxine"],"drugbank":["DB06150"],"chEBI":["32161"]},"childChemblIds":["CHEMBL2107253"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease. It was withdrawn in United States."}
{"id":"CHEMBL682","canonicalSmiles":"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O","inchiKey":"OVCDSSHSILBFBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMODIAQUINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amodiaquin","Amodiaquine","GNF-Pf-5648","NSC-13453","SJ000110703"],"crossReferences":{"PubChem":["50085969"],"Wikipedia":["Amodiaquine"],"drugbank":["DB00613"],"chEBI":["2674"]},"childChemblIds":["CHEMBL1357648","CHEMBL1630","CHEMBL3137745","CHEMBL1707005","CHEMBL3216010"],"count":3,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for malaria and has 2 investigational indications."}
{"id":"CHEMBL6966","canonicalSmiles":"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC","inchiKey":"SGTNSNPWRIOYBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERAPAMIL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-16,533-1","CP-16533-1","CP-165331","Calan","Covera-HS","D-365","Iproveratril","Isoptin","NSC-272306NA","Tarka","Verapamil","Verelan"],"crossReferences":{"DailyMed":["verapamil%20hydrochloride"],"PubChem":["104171262","124881789","124881790","124881792","124881795","144203851","170464904","174316170","26751825","50104518","50104519","50104520","90340771"],"Wikipedia":["Verapamil"],"drugbank":["DB00661"],"chEBI":["77733"]},"childChemblIds":["CHEMBL1280","CHEMBL1707604","CHEMBL483787"],"count":15,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0003777","HP_0002140","EFO_0000275","HP_0004763","EFO_1001413","EFO_0000319","Orphanet_558","EFO_0003843","EFO_0000384","EFO_1000994","EFO_0000537","MP_0001914","EFO_0003890","Orphanet_33069","MONDO_0100096","EFO_0000289","EFO_0004253","EFO_0003144","EFO_0001359","HP_0004308","EFO_0004616","EFO_0008583","EFO_0004212","EFO_0000183","EFO_0001360","EFO_0000407"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for cardiovascular disease and has 14 investigational indications."}
{"id":"CHEMBL70176","canonicalSmiles":"COc1ccc(S(=O)(=O)N(Cc2cccnc2)c2c(C)cccc2C(=O)NO)cc1","inchiKey":"AINJYWXKBKRQSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL70176","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02071"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL703","canonicalSmiles":"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C","inchiKey":"AXOIZCJOOAYSMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUXAMETHONIUM","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anectine","Quelicin","Succinylcholine","Sucostrin","Suxamethonium"],"crossReferences":{"DailyMed":["succinylcholine%20chloride"],"PubChem":["11111825","90341285"],"drugbank":["DB00202"],"chEBI":["45652"]},"childChemblIds":["CHEMBL2104486","CHEMBL3391771","CHEMBL983"],"count":2,"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0003326","MONDO_0002050","HP_0001662","EFO_0005323","EFO_0000712","EFO_0002950"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL716","canonicalSmiles":"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1","inchiKey":"URKOMYMAXPYINW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUETIAPINE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atrolak xl","Biquelle xl","Brancico xl","Ebesque xl","Mintreleq xl","Psyquet xl","Seotiapim xl","Seroquel","Seroquel xl","Sondate xl","Tenprolide xl","Zaluron xl"],"synonyms":["Quetiapine"],"crossReferences":{"DailyMed":["quetiapine%20fumarate"],"PubChem":["144205090","170465146","26749928","29215183","49666155"],"Wikipedia":["Quetiapine"],"drugbank":["DB01224"],"chEBI":["8707"]},"childChemblIds":["CHEMBL1200911","CHEMBL3188993"],"count":25,"approvedIndications":["EFO_0005407","EFO_0005411"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0004938","EFO_0002610","EFO_0005687","EFO_0004262","MONDO_0002009","HP_0000726","EFO_0007453","EFO_0009267","EFO_1001917","EFO_0004698","EFO_0003829","MONDO_0002046","EFO_0007191","EFO_0004247","EFO_0000289","MONDO_0002050","EFO_0004257","EFO_0003761","EFO_0009854","EFO_0004701","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0004215","EFO_0003888","HP_0012076","EFO_0002508","EFO_0000677","EFO_1000904","EFO_0009963","EFO_0005407","EFO_0001358","EFO_1001918","HP_0000713","EFO_0003885","EFO_1001892","EFO_0003890","MONDO_0002491","Orphanet_79292","EFO_0005411"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for psychosis and schizoaffective disorder and has 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL826","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21","inchiKey":"IDYZIJYBMGIQMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENOXACIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Comprecin","Flumark","Penetrex"],"synonyms":["AT-2266","CI-919","Enoxacin","NSC-629661","PD 107779","PD-107779"],"crossReferences":{"PubChem":["11112842","124882681","144204239","160657818","170465263","174006234","494643","855964"],"Wikipedia":["Enoxacin"],"drugbank":["DB00467"],"chEBI":["157175"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL8706","canonicalSmiles":"C#CCN(C)CCCOc1ccc(Cl)cc1Cl","inchiKey":"BTFHLQRNAMSNLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORGILINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clorgiline","Clorgyline","M&B 9302","clorgyline"],"crossReferences":{"PubChem":["11111452","11111453","90341614"],"Wikipedia":["Clorgiline"],"drugbank":["DB04017"],"chEBI":["3763"]},"childChemblIds":["CHEMBL539507"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL87708","canonicalSmiles":"CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1","inchiKey":"SAPNXPWPAUFAJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOFEPRAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lofepramine"],"crossReferences":{"PubChem":["50111779","50111780"],"Wikipedia":["Lofepramine"],"drugbank":["DB13411"],"chEBI":["47782"]},"childChemblIds":["CHEMBL2106638"],"count":1,"approvedIndications":["EFO_0003761"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL89705","canonicalSmiles":"Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4ccc(N(CCCl)CCCl)cc4)cn3C)cn2C)cc1C(=O)NCCC(=N)N","inchiKey":"ARKYUICTMUZVEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALLIMUSTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tallimustine"],"crossReferences":{"drugbank":["DB15466"]},"childChemblIds":["CHEMBL545612"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL902","canonicalSmiles":"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1","inchiKey":"XUFQPHANEAPEMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAMOTIDINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Famotidine","Famotidine preservative free","Famotidine preservative free (pharmacy bulk)","Fluxid","Pepcid","Pepcid ac","Pepcid preservative free","Pepcid rpd"],"synonyms":["Famotidine","L 643341","MK-208","YM-11170"],"crossReferences":{"DailyMed":["famotidine"],"PubChem":["11111194","11111195","144203704","144212144","170464877","26748463","26753575","49681730","50106279","85231052","855518"],"TG-GATEs":["85"],"Wikipedia":["Famotidine"],"drugbank":["DB00927"],"chEBI":["4975"]},"count":19,"approvedIndications":["EFO_0003948","HP_0004398","EFO_0000685","EFO_0002506"],"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000685","HP_0002239","EFO_0004280","EFO_0000756","MONDO_0004670","EFO_0000180","MONDO_0043839","MONDO_0020657","EFO_0003060","EFO_0002609","EFO_0000311","EFO_0008533","EFO_1001951","HP_0004398","MONDO_0001056","EFO_0003948","EFO_0009454","EFO_0004232","MONDO_0100096","EFO_0002506","EFO_0006890","EFO_0000764","EFO_0000676","EFO_0000641","EFO_0000692","EFO_0009878"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 approved and 15 investigational indications."}
